Targeting purinergic signaling for perioperative organ protection

Anesthesiology

Volumn 118, Issue 5, 2013, Pages 1001-1004

  Eltzschig, Holger K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; CYCLIC AMP; ERYTHROPOIETIN; G PROTEIN COUPLED RECEPTOR; HYPOXIA INDUCIBLE FACTOR; LIGAND GATED ION CHANNEL; PURINERGIC P2 RECEPTOR; TRANSCRIPTION FACTOR SP1;

ACUTE LUNG INJURY; EXTRACELLULAR SPACE; HEART INFARCTION; INTESTINE ISCHEMIA; MORBIDITY; MORTALITY; ORGAN INJURY; ORGAN PROTECTION; ORGAN TRANSPLANTATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTECTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; STRESS ECHOCARDIOGRAPHY;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANESTHETICS; ANOXIA; HUMANS; INFLAMMATION; POSTOPERATIVE COMPLICATIONS; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EID: 84877580341     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182874686     Document Type: Review

References (21)

1. Eltzschig HK, Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med 2011; 17:1391-401
2. Eltzschig HK, Sitkovsky MV, Robson SC: Purinergic signaling during inflammation. N Engl J Med 2012; 367:2322-33
3. Eltzschig HK, Carmeliet P: Hypoxia and inflammation. N Engl J Med 2011; 364:656-65
4. Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, MacDonald JA, Muruve DA, McKay DM, Beck PL, Mawe GM, Thompson RJ, Sharkey KA: Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med 2012; 18:600-4
5. Colgan SP, Eltzschig HK: Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol 2012; 74:153-75
6. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F, Virchow JC Jr, Lambrecht BN: Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007; 13:913-9
7. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK: Hypoxiainducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 2009; 10:195-202
8. Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, Walker LA, Lowes BD, Han J, Borchers CH, Buttrick PM, Kominsky DJ, Colgan SP, Eltzschig HK: Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med 2012; 18:774-82
9. Eckle T, Grenz A, Laucher S, Eltzschig HK: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 2008; 118:3301-15
10. Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, Tak E, McNamee EN, Clambey E, Moldovan R, Reyes G, Klawitter J, Ambler K, Magee K, Christians U, Brodsky KS, Ravid K, Choi DS, Wen J, Lukashev D, Blackburn MR, Osswald H, Coe IR, Nürnberg B, Haase VH, Xia Y, Sitkovsky M, Eltzschig HK: Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 2012; 122:693-710
11. Grenz A, Osswald H, Eckle T, Yang D, Zhang H, Tran ZV, Klingel K, Ravid K, Eltzschig HK: The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 2008; 5:e137
12. Eltzschig HK, Köhler D, Eckle T, Kong T, Robson SC, Colgan SP: Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 2009; 113:224-32
13. Hart ML, Grenz A, Gorzolla IC, Schittenhelm J, Dalton JH, Eltzschig HK: Hypoxia-inducible factor-1a-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor. J Immunol 2011; 186:4367-74
14. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP: Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002; 110:993-1002
15. Eltzschig HK: Adenosine: An old drug newly discovered. Anesthesiology 2009; 111:904-15
16. Eckle T, Köhler D, Lehmann R, El Kasmi K, Eltzschig HK: Hypoxia-inducible factor-1 is central to cardioprotection: A new paradigm for ischemic preconditioning. Circulation 2008; 118:166-75
17. Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK: Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007; 115:1581-90
18. Hart ML, Jacobi B, Schittenhelm J, Henn M, Eltzschig HK: Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol 2009; 182:3965-8
19. Morote-Garcia JC, Rosenberger P, Nivillac NM, Coe IR, Eltzschig HK: Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 2009; 136:607-18
20. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK: HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 2008; 111:5571-80
21. Bernhardt WM, Wiesener MS, Scigalla P, Chou J, Schmieder RE, Günzler V, Eckardt KU: Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol 2010; 21:2151-6